tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

CRNX Stock Latest News

Crinetics Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 8, 2024
Press ReleasesCrinetics Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 8, 2024
7d ago
CRNX
Crinetics Pharmaceuticals Announces July 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PremiumPress Releases
Crinetics Pharmaceuticals Announces July 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
15d ago
CRNX
3 Best Stocks to Buy Now, 7/10/2024, According to Top Analysts
PremiumMarket News
3 Best Stocks to Buy Now, 7/10/2024, According to Top Analysts
16d ago
APLD
CRNX
Crinetics price target raised to $54 from $47 at JPMorgan
PremiumThe Fly
Crinetics price target raised to $54 from $47 at JPMorgan
17d ago
CRNX
Crinetics files to sell common stock for holders, no amount given
PremiumThe Fly
Crinetics files to sell common stock for holders, no amount given
1M ago
CRNX
Crinetics files automatic mixed securities shelf
PremiumThe FlyCrinetics files automatic mixed securities shelf
1M ago
CRNX
EY Announces Scott Struthers, Ph.D., CEO and Founder of Crinetics Pharmaceuticals, as an Entrepreneur Of The Year® 2024 Pacific Southwest Award Winner
PremiumPress Releases
EY Announces Scott Struthers, Ph.D., CEO and Founder of Crinetics Pharmaceuticals, as an Entrepreneur Of The Year® 2024 Pacific Southwest Award Winner
1M ago
CRNX
Crinetics Pharmaceuticals Announces June 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PremiumPress Releases
Crinetics Pharmaceuticals Announces June 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2M ago
CRNX
Crinetics price target raised to $74 from $55 at Oppenheimer
PremiumThe Fly
Crinetics price target raised to $74 from $55 at Oppenheimer
2M ago
CRNX
3 Best Stocks to Buy Now, 6/4/2024, According to Top Analysts 
PremiumMarket News
3 Best Stocks to Buy Now, 6/4/2024, According to Top Analysts 
2M ago
CRNX
RBRK
Crinetics Pharmaceuticals Showcases Promising Drug Advances
PremiumCompany Announcements
Crinetics Pharmaceuticals Showcases Promising Drug Advances
2M ago
8K
CRNX
Crinetics announces initial findings for atumelnant in two ongoing studies
PremiumThe Fly
Crinetics announces initial findings for atumelnant in two ongoing studies
2M ago
CRNX
Crinetics Announces Positive Initial Findings at ENDO 2024 for Atumelnant in Two Ongoing, Open-Label Studies for the Treatment of Congenital Adrenal Hyperplasia (CAH) and ACTH-Dependent Cushing’s Syndrome (ADCS)
PremiumPress ReleasesCrinetics Announces Positive Initial Findings at ENDO 2024 for Atumelnant in Two Ongoing, Open-Label Studies for the Treatment of Congenital Adrenal Hyperplasia (CAH) and ACTH-Dependent Cushing’s Syndrome (ADCS)
2M ago
CRNX
Crinetics Pharmaceuticals Appoints Robert M. Cuddihy, M.D., as Senior Vice President of Medical Affairs
PremiumPress Releases
Crinetics Pharmaceuticals Appoints Robert M. Cuddihy, M.D., as Senior Vice President of Medical Affairs
2M ago
CRNX
Crinetics price target raised to $75 from $65 at Cantor Fitzgerald
PremiumThe Fly
Crinetics price target raised to $75 from $65 at Cantor Fitzgerald
2M ago
CRNX
Crinetics price target raised to $62 from $52 at Baird
PremiumThe Fly
Crinetics price target raised to $62 from $52 at Baird
2M ago
CRNX
RBC still sees gradual uptake for Neurocrine after competitor data
PremiumThe Fly
RBC still sees gradual uptake for Neurocrine after competitor data
2M ago
CRNX
NBIX
Neurocrine competitive data should be kept in perspective, says Evercore
PremiumThe Fly
Neurocrine competitive data should be kept in perspective, says Evercore
2M ago
CRNX
NBIX
Crinetics announces early release of ENDO 2024 abstracts
PremiumThe Fly
Crinetics announces early release of ENDO 2024 abstracts
2M ago
CRNX
Crinetics Pharmaceuticals Announces Early Release of ENDO 2024 Late-Breaking Abstracts
PremiumPress ReleasesCrinetics Pharmaceuticals Announces Early Release of ENDO 2024 Late-Breaking Abstracts
2M ago
CRNX
Crinetics participates in a conference call with Cantor Fitzgerald
PremiumThe Fly
Crinetics participates in a conference call with Cantor Fitzgerald
2M ago
CRNX
Crinetics Pharmaceuticals Announces May 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PremiumPress Releases
Crinetics Pharmaceuticals Announces May 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3M ago
CRNX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >